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ABSTRACT
Adults with type 2 diabetes (T2D) have a higher fracture risk for a given bone quantity, but the mechanisms remain unclear.
Using a rat model of polygenic obese T2D, we demonstrate that diabetes signiﬁcantly reduces whole-bone strength for a given
bone mass (mCT-derived BMC), and we quantify the roles of T2D-induced deﬁcits in material properties versus bone structure; ie,
geometry and microarchitecture. Lumbar vertebrae and ulnae were harvested from 6-month-old lean Sprague-Dawley rats,
obese Sprague-Dawley rats, and diabetic obese UCD-T2DM rats (diabetic for 69 7 days; blood glucose >200mg/dL). Both
obese rats and those with diabetes had reduced whole-bone strength for a given BMC. In obese rats, this was attributable to
structural deﬁcits, whereas in UCD-T2DM rats, this was attributable to structural deﬁcits and to deﬁcits in tissue material
properties. For the vertebra, deﬁcits in bone structure included thinner and more rod-like trabeculae; for the ulnae, these deﬁcits
included inefﬁcient distribution of bone mass to resist bending. Deﬁcits in ulnar material properties in UCD-T2DM rats were
associated with increased non-enzymatic crosslinking and impaired collagen ﬁbril deformation. Speciﬁcally, small-angle X-ray
scattering revealed that diabetes reduced collagen ﬁbril ultimate strain by 40%, and those changes coincided with signiﬁcant
reductions in the elastic, yield, and ultimate tensile properties of the bone tissue. Importantly, the biomechanical effects of these
material property deﬁcits were substantial. Prescribing diabetes-speciﬁc tissue yield strains in high-resolution ﬁnite element
models reduced whole-bone strength by a similar amount (and in some cases a 3.4-fold greater amount) as the structural
deﬁcits. These ﬁndings provide insight into factors that increase bone fragility for a given bone mass in T2D; not only does
diabetes associate with less biomechanically efﬁcient bone structure, but diabetes also reduces tissue ductility by limiting
collagen ﬁbril deformation, and in doing so, reduces the maximum load capacity of the bone. © 2018 American Society for Bone
and Mineral Research.
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Introduction
Prevention of fragility fractures, which cause signiﬁcantmorbidity and societal expense, is an important goal for the
elderly. The urgency of this goal is increasing with the growing
size of the elderly population, and is magniﬁed by the global
epidemic of type 2 diabetes (T2D). T2D is an independent risk
factor for fracture,(1,2) even after accounting for traditional risk
factors more prevalent in diabetics, such as neuropathy,
decreased visual acuity, and falls.(3–6) Importantly, adults with
T2D have a higher fracture risk for a given areal BMD(7)—the
main clinical predictor of fracture risk. Identifying the character-
istics that make diabetic bone weaker for a given bone mass,
which is highly correlated with areal BMD,(8) could motivate
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more accurate diagnostic tools and new therapeutic targets for
managing fracture risk in patients with T2D.
Bones derive their resistance to deformation and fracture
from physical characteristics that span multiple length scales,
and several of these characteristics are independent of bone
mass and BMD and could be impaired by T2D. At the nanoscale,
collagen ﬁbril stretching and sliding confer ductility to the
tissue, which provides resistance to crack initiation and
growth.(9) In T2D, hyperglycemia results in several changes to
the organic matrix that could impact collagen behavior,
including increases in the formation of advanced glycation
end-products (AGEs) that can crosslink the collagen ﬁbrils.(10,11)
Although AGE accumulation could reduce ﬁbril stretching and
sliding and thereby reduce tissue ductility, evidence of this
mechanism in a diabetic milieu is limited. In one study, levels of
the AGE pentosidine were signiﬁcantly higher in femurs from
diabetic WBN/Kob rats, and pentosidine concentration was
negatively correlatedwithwhole-bone stiffness and strength.(12)
Silva and colleagues(13) reported that elevated pentosidine in
ulnae from rats with type 1 diabetes coincided with reduced
tissue strength. Compromised tissue behavior has also been
reported in humans with T2D,(14) although the mechanisms
remain unclear.
In addition to altering the physical properties of the collagen,
AGEaccumulation could reducebone strengthby impairingbone
structure; ie, geometry and microarchitecture. Optimal bone
structure is needed to ensure efﬁcient distribution of mechanical
stresses, which inﬂuence the propensity for structural failure(15)
and thus directly contribute to the maximal force and energy a
bone can withstand. In T2D, excessive AGE accumulation could
hinder the bone cells’ ability to maintain optimal geometry and
microarchitecture. For example, AGEs reduce the rate of matrix
resorption.(16,17) AGEs can also inhibit the phenotypic expression
of osteoblasts,(18) interfere with osteoclast differentiation,(17) and
stimulate secretion of catabolic and proinﬂammatory factors.(19)
Accordingly, increased AGE accumulation with diabetes may
underlie the impairments in cortical geometry and trabecular
microarchitecture that have been reported in rodent mod-
els.(20–22) In humans, cortical porosity is signiﬁcantly higher at the
distal radius(23,24) and distal tibia(25) in some cohorts with T2D,
including cohorts with a fracture.(26) There is also evidence of
thinner cortices at the femoral neck in postmenopausal women
with T2D who fracture.(27)
To understand how T2D heightens bone fragility, prior
studies measured tissue material properties (or AGE concen-
trations), cortical/trabecular microarchitecture, and whole-
bone biomechanical behavior. However, because it was
difﬁcult to observe collagen ﬁbril deformations, the basis for
any tissue material defects is unclear. Likewise, because the
net biomechanical effects of material properties and bone
structure on whole-bone strength are intertwined, the relative
roles of any deﬁcits in these characteristics resulting from
concurrent T2D also remain unknown. This knowledge may be
important for accurately assessing fracture risk in T2D and for
developing treatment strategies. We addressed these issues in
a well-characterized and validated rat model of T2D.(28) For the
ﬁrst time, we measured collagen ﬁbril deformation using
small-angle X-ray scattering (SAXS), and we estimated the
relative contributions of tissue material properties and bone
structure using mCT-based ﬁnite element analysis. Using this
approach, we sought to test the hypothesis that deﬁcits in
tissue material properties in T2D signiﬁcantly reduce whole-
bone strength.
Materials and Methods
Study design
This study was designedwith two aims: (i) to evaluate the effects
of T2D on tissue material properties; and (ii) to measure the
contributions of any T2D-induced deﬁcits in tissue material
properties on whole-bone biomechanical behavior. To evaluate
the effects of T2D, we used a well-established rat model and
control animals for the effects of age, disease duration, insulin
resistance, obesity, and glycemic control. Developed and
validated at the University of California, Davis, the UCD-T2DM
rat mimics the pathophysiology of human T2D.(28) Generated by
crossing two lines of nondiabetic rats—one with adult-onset
obesity and insulin resistance, without defects in either leptin
production or leptin receptor signaling (obese Sprague-Dawley
[OSD]) and one with defective pancreatic beta cell islet function
and insulin secretion (ZDF-lean)—the UCD-T2DM rats demon-
strate diabetes in both sexes with adult-onset obesity, insulin-
resistance, impaired glucose tolerance, and eventual beta cell
decompensation. We compared the UCD-T2DM rats to two
nondiabetic controls: lean Sprague Dawley (LSD) and OSD rats.
By comparing the UCD-T2DM rats to OSD rats, which are a
genetically similar, obese and insulin-resistant control, we
sought to disentangle the effects of hyperglycemia from the
effects of obesity and insulin resistance, which could indepen-
dently affect bone behavior.(29–31)
We also measured the contribution of tissue material
properties to whole-bone behavior. This is difﬁcult to achieve
through biomechanical testing alone, so we coupled the tests
with high-resolution, mCT-based ﬁnite element analysis of the
same bones. This approach enabled us to simulate a
hypothetical scenario: How do bones from diabetic rats behave
biomechanically when given the average tissue material
properties measured from healthy control rats? By comparing
the biomechanical behavior of these hypothetical bones with
bones from the diabetic rats having their measured (specimen-
speciﬁc) material properties, we assessed the unique contribu-
tion of tissue material properties. And, by comparing the
behavior of the hypothetical bones with bones from healthy rats
having identical material properties, we quantiﬁed the contri-
butions of bone geometry/microarchitecture—the only remain-
ing variable in the models.
Animals and tissues
Rats were maintained and studied in accordance with
Institutional Animal Care and Use Committee–approved proto-
cols at the University of California, Davis (UCD). Ulnae and fourth
lumbar (L4) vertebrae were harvested from rats following
euthanasia with an overdose of pentobarbital. Six-month-old
LSD rats (“control”), OSD rats (“obese”), and UCD-T2DM rats
(“diabetic”; n¼ 4 to 6 rats/group) were studied. The generation
and phenotypes of these rats has been described.(28) Non-fasted
blood glucose was monitored every 2 weeks with a glucose
meter to determine the age of diabetes onset (blood glucose
concentration>200mg/dL on two consecutive measurements).
As described, blood was collected for measurement of
circulating glucose, insulin, and glycated hemoglobin (HbA1c)
after an overnight fast at the time of euthanasia.(32)
Ulnae and vertebrae were cleaned of soft tissues, and the
vertebral posterior elements were embedded in epoxy and
mounted in a custom holder of a low-speed diamond-blade
precision saw. Cranial and caudal endplates were removedwhile
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under irrigation to produce vertebral bodies with plano-parallel
end surfaces and similar vertebral heights.
mCT
Right ulnae (15-mm-long region) and L4 vertebrae (after
endplate removal) were imaged with mCT (mCT50; Scanco
Medical AG, Br€uttisellen, Switzerland) to measure tissue
mineralization, bone geometry, and vertebral trabecular micro-
architecture (Fig. 1). Bone geometry parameters included ulnar
moments of inertia relative to the anterior-posterior andmedial-
lateral axes at the mid-span (Iap and Iml, respectively) and
averaged for entire scan region (Iap-avg and Iml-avg), cross-
sectional area (ulnae; A), and relative mass of the cortical shell
(vertebrae; Ct.M(33)). Imaging was performed with a 55-kVp
potential, 145-mA current, and 16-mm voxels (ulnae) or 6-mm
voxels (vertebrae). Voxel attenuation was converted to mineral
density using a 1200-mg hydroxyapatite (HA)/cm3 phantom.
Bone mass (bone mineral content [BMC]) was the total mineral
density for all bone voxels calculated after applying a global
threshold to the mCT images, and was used as the surrogate for
bone quantity in the rats.
Biomechanical testing
After imaging, right ulnae and vertebrae were destructively
tested to measure whole-bone biomechanical properties and
estimated material properties. Ulnae were loaded to failure in
three-point-bending by placing each bone on two supports
(span, L¼ 15mm) and applying a laterally directed displacement
(d) to the medial aspect of the mid-diaphysis at a rate of
0.01mm/s. Vertebrae were compressed to failure between
platens at a rate of 0.5% strain/s. All tests were performed on
hydrated bones at room temperature using either an electro-
mechanical (ulnae) or servohydraulic load frame (vertebrae).
Force (F) and displacement data were converted to moments
(ulnae,M¼ FL/4) and normalized displacement (ulnae, d0 ¼ 12d/
L2), and plots ofM versus d0 (ulnae) or F versus d (vertebrae) were
used to calculate whole-bone stiffness, yield force, and ultimate
force. We then estimated ulnar tissue material properties (tissue
modulus, yield stress, and ultimate stress) using themCT-derived
geometric parameters and beam theory.(13)
Synchrotron small-angle X-ray scattering
Collagen ﬁbril deformation during uniaxial tension testing of the
left ulnae was measured using synchrotron SAXS. This approach
permits simultaneous, real-time measurement during the tensile
test of the speciﬁc strain carried by the collagen ﬁbrils as
compared to thebulk tissue strain. Thedistal andproximal endsof
the ulnae were glued to sandpaper strips and secured between
clamps. In situ tensile testswereperformedonhydratedulnaeat a
displacement rate of 5mm/s with a TST350 Tensile Testing Stage
(Linkam Scientiﬁc Inc., Tadworth, United Kingdom). During
testing, the mid-shaft was exposed to X-ray beams of 10 keV
energy for1 s every7.5 s (450-mm 350-mmbeamwindow). Total
radiation was limited to 30 kGy to minimize any effects on
mechanical behavior.(34) The collagen d-spacing, ie, regular
staggering pattern of the collagen triple helices, was measured
from shifts in the Bragg peak positions at increasing amounts of
load and converted to collagen ﬁbril strain by normalizing to the
d-spacing at zero load. Tissue stress was calculated from cross-
sectional area measurements of contralateral ulnae. Detailed
explanations on calculation of strain in the collagen ﬁbrils and
bone tissue have been described.(35) SAXS was performed at
beamline 7.3.3(36) at the Advanced Light Source (Lawrence
Berkeley National Laboratory, Berkeley, CA, USA).
Biochemical analysis of AGE accumulation
A ﬂuorimetric assay was used to measure the concentration of
AGEs in the left ulnae following SAXS. Mid-diaphyseal sections
were ﬁrst decalciﬁed in EDTA and then hydrolyzed in 6N HCl (24
hours, 110°C). Fluorescence readings of the neutralized lysates
(excitation 370nm, emission440nm)were referenced to aquinine
sulfate standard(37) and then normalized to the collagen content,
which was calculated from the amount of hydroxyproline.(38)
Finite element modeling
To study the relative contributions of T2D-induced differences in
tissue material properties versus bone geometry and micro-
architecture, we performed ﬁnite element modeling for the
ulnae and vertebrae that had been destructively tested. Finite
element models were constructed from eachmCT scan using 16-
mm-sided (ulnae) or 6-mm-sided (vertebrae) cube-shaped
elements. We considered two cases of tissuematerial properties.
In the ﬁrst case, we assigned each element of the bones from the
Fig. 1. L4 vertebrae (without endplates) and right ulnae (15-mm-long
region from themid-shaft) from lean control rats, obese nondiabetic rats,
and diabetic obese rats. Bones were scanned with mCT prior to
mechanical testing, and the scans were then used to create high-
resolution ﬁnite element models. Mineral density–shaded cross-sections
from obese rats and those with diabetes illustrate differences in bone
geometry and trabecular microarchitecture compared to those from
lean controls.
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UCD-T2DM rats a Young’s modulus that was based on its voxel-
speciﬁc tissue mineral density using a previously published
power-law relationship.(39) In the second case, we assigned each
element the mean Young’s modulus that was determined for all
elements in the models belonging to the bones from LSD
controls from the same anatomic site. A Poisson’s ratio of 0.3 was
used in both cases.
High-resolution, linearly elastic ﬁnite element analysis was
used to determine whole-bone stiffness (vertebrae) or rigidity
(ulnae). For the ulnae, we simulated three-point bending by
applying a laterally directed displacement to the nodes at the
medial aspect of themid-diaphysis while constraining the nodes
at the lateral aspect of the distal and proximal ends in the
medial-lateral direction. Uniaxial compression was applied to
the vertebrae, with the nodes along the cranial and caudal
surfaces free to move in-plane.
We also performed geometrically and materially nonlinear
analysis using the tissue properties measured from the SAXS
experiments. Here, bone tissue was modeled using a rate-
independent elastoplasticity model(40) and homogeneous
isotropic tissue material properties: animal-speciﬁc Young’s
modulus and tensile yield strain measured by SAXS, Poisson’s
ratio of 0.3, and a compressive yield strain of 0.69%.(41) For the
hypothetical case, bones from UCD-T2DM rats were assigned
the mean Young’s modulus and mean tensile yield strain that
wasmeasured for the control bones by SAXS. Owing to the large
size of the models (up to 87 million elements each), nonlinear
ﬁnite element analysis was carried out for a subset of ulnae and
vertebrae. Simulations were performed at the Texas Advanced
Computing Center (University of Texas at Austin, Austin, TX,
USA) using an implicit, parallel ﬁnite element code.(42)
Outcomes and statistics
To test our hypothesis that diabetes coincides with deﬁcits in
tissue material properties and bone structure, we used ANOVA
with Tukey-Kramer post hoc tests to determinegroupdifferences.
Despite the small sample size per group, parametric tests were
used because the data did not violate the normality assumption
(p > 0.05, Shapiro-Wilk test) or equal variance assumption. We
also compared ratios of whole-bone biomechanical properties
(stiffness, yield force, ultimate moment, etc.) to BMC between
groups. This allowed us to compare the biomechanical perfor-
mance of bones that were different sizes and to determine if
diabetes associated with lower whole-bone strength for a given
bonemass. Importantly, this approach is analogous to comparing
regressionmodels ofbiomechanical properties versus bonemass,
and it yields similar conclusions about the existence of factors
beyond bone quantity that may be contributing to differences in
whole-bone biomechanical properties.(43) To evaluate the
contributions of material property deﬁcits versus structural
deﬁcits in T2D, we performed two comparisons. First, unpaired
t tests were used to compare ﬁnite element–predicted
biomechanical properties between bones from LSD and UCD-
T2DM rats that were assigned the same material properties
(effects of bone structure only). Next, paired t tests were used to
comparepredictionsbetween thebones fromtheUCD-T2DMrats
with andwithout specimen-speciﬁcmaterial properties (effects of
material properties only). Statistical tests were performed with
JMP 12 Pro (SAS Institute, Inc., Cary, NC, USA). Signiﬁcance is
deﬁned by p< 0.05. Data are given as mean SE.
Results
Blood glucose levels indicated that the UCD-T2DM rats were
diabetic for 69 7 days (range, 46 to 89 days) at the time of
euthanasia. Body weights, blood glucose, and HbA1c for these
same rats were reported previously.(32) Of note, obese OSD rats
and those with diabetes had signiﬁcantly higher body weights
than age-matched lean LSD controls. Whereas both OSD and
UCD-T2DM rats had over twofold higher insulin levels
(1.4 0.3 ng/mL) indicative of insulin resistance compared
with lean LSD controls (0.6 0.07 ng/mL), only the UCD-T2DM
rats were hyperglycemic (HbA1c 11.8% 1.28% versus
4.5% 0.09% and 4.3% 0.06% in LSD and OSD rats, respec-
tively; p< 0.0001).
T2D and obesity reduce whole-bone biomechanical
properties for a given bone mass
At the whole-bone level, obese rats and those with diabetes had
signiﬁcantly reduced whole-bone biomechanical properties per
unit bone mass. Overall, obese rats had improved vertebral
stiffness, yield force, andultimate force,while diabeticUCD-T2DM
rats generally had inferior properties (Table 1). However, both
obese rats and those with diabetes had signiﬁcantly higher ulnar
BMC (Table 2), and the biomechanical properties were highly
correlated with BMC (r2¼ 0.49 to 0.76; p< 0.005). To identify
whether factorsbeyondBMCmayhavecontributed todifferences
in whole-bone biomechanical properties, we compared ratios of
whole-bone stiffness-to-BMC and strength-to-BMC between
groups.(43) After normalizing the properties by BMC, the OSD
and UCD-T2DM rats had 47% and 22% lower vertebral stiffness,
respectively (p< 0.01; Fig. 2A); 23% lower yield force (p< 0.005;
Fig. 2B); and 27% lower ultimate force (p< 0.001; Fig. 2C).
Similarly, per unit BMC, the ulnae from OSD and UCD-T2DM rats
Table 1. Biomechanical Properties of Vertebrae and Ulnae Determined by Uniaxial Compression and Three-Point Bending (Mean SE)
Lean (n¼ 6 rats) Obese (n¼ 6 rats) Diabetic (n¼ 6 rats) ANOVA p
Vertebra (compression)
Stiffness (kN/mm) 4.16 0.21 4.84 0.15 3.53 0.16a,b <0.001
Yield force (N) 290 24 439 23a 243 20b <0.001
Ultimate force (N) 335 29 483 18a 267 23b <0.001
Ulna (bending)
Rigidity (kN-mm2) 4.49 0.21 4.51 0.14 3.83 0.17a,b 0.024
Yield moment (N-mm) 96.6 6.0 95.8 3.3 74.4 7.2a,b 0.022
Ultimate moment (N-mm) 110.9 6.4 106.1 3.0 100.2 6.7 0.420
ap< 0.05 versus control by post hoc test.
bp< 0.05 versus obese by post hoc test.
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had 17% to 26% lower rigidity (p< 0.001; Fig. 2D), 22% to 32%
lower yield moment (p< 0.05; Fig. 2E), and 22% lower ultimate
moment (p< 0.01; Fig. 2F).
T2D and obesity compromise vertebral geometry and
microarchitecture
The reduced whole-bone stiffness and strength measured for a
given bone mass coincided with signiﬁcant deﬁcits in vertebral
geometry and trabecular microarchitecture (Table 2). Compared
to lean controls, vertebrae from diabetic rats demonstrated 33%
lower bone volume fraction (BV/TV, p< 0.001) and trabeculae
that were 14% thinner (Tb.Th, p< 0.01) and more rod-like (SMI,
p< 0.01). In the OSD rats, the higher bonemass reﬂected a larger
trabecular compartment, because the relativemass of the cortical
bone was 15% lower (Ct.M, p< 0.001 versus lean control).
In the ulnae, both OSD and UCD-T2DM rats had 15% to 20%
greater bone mass (p< 0.005). However, the additional bone
Table 2. Bone Mass, Geometry, and Microarchitecture Determined From mCT (Mean SE)
Lean (n¼ 5–6 rats) Obese (n¼ 6 rats) Diabetic (n¼ 6 rats) ANOVA p
Vertebra
Bone mass, BMC (mg) 17.0 1.7 33.1 2.4a 19.1 1.1b <0.001
BV/TV 0.29 0.01 0.28 0.02 0.20 0.01a,b <0.001
Tb.N (mm–1) 3.4 0.1 3.7 0.2 3.0 0.1b 0.009
Tb.Th (mm) 0.084 0.001 0.080 0.002 0.073 0.003a,b 0.003
Tb.Sp (mm) 0.269 0.010 0.237 0.014 0.304 0.011b 0.005
Conn.D (mm–3) 57 5 97 9a 64 7b 0.003
DA 1.76 0.02 1.83 0.04 1.81 0.02 0.240
SMI -0.07 0.06 0.53 0.2a 0.99 0.08a,b <0.001
TMD (mg HA/cm3) 1229 7 1198 6a 1194 9a 0.011
Ct.M (%) 70 1 59 3a 71 2 0.006
Vertebral height (mm) 4.04 0.07 4.32 0.10 4.29 0.07 0.220
Ulna
Bone mass, BMC (mg) 38.5 1.2 45.4 0.6a 43.7 1.2a <0.001
Iap (mm
4) 0.25 0.02 0.24 0.01 0.24 0.02 0.849
Iap-avg (mm
4) 0.26 0.02 0.27 0.01 0.26 0.02 0.702
Iml (mm
4) 0.65 0.03 1.13 0.07a 1.07 0.05a <0.001
Iml-avg (mm
4) 0.82 0.03 1.47 0.07a 1.28 0.07a <0.001
Section modulus, (mm3) 0.38 0.02 0.39 0.02 0.40 0.02 0.741
TMD (mg HA/cm3) 1293 12 1253 7a 1234 6a <0.001
ap< 0.05 versus control by post hoc test.
bp< 0.05 versus obese by post hoc test.
Fig. 2. Obese rats and those with diabetes showed signiﬁcant reductions in whole-bone biomechanical properties per unit bone mass, BMC. Vertebral
properties (A–C) weremeasured in compression; ulnarmid-shaft properties (D–F) weremeasured in three-point bending. Data aremean SE for n¼ 5 to
6 rats/group. ap< 0.01 versus control; bp< 0.01 versus obese; cp< 0.05 versus control; dp< 0.05 versus obese.
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mass in these groups mainly beneﬁted resistance to anterior-
posterior bending (higher Iml; Table 2), which provides minimal
resistance to medial-lateral bending despite the larger cross-
sectional area. Section modulus and moment of inertia relative
to the anterior-posterior axis (Iap) were similar in all groups. This
suggests that the T2D-related reductions in ulnar rigidity/BMC,
yield moment/BMC, and ultimate moment/BMC are mainly
attributable to deﬁcits in tissue material behavior.
T2D impairs tissue material properties and reduces
collagen fibril ultimate strain
In the UCD-T2DM rats with hyperglycemia, the observed
impairments in whole-bone biomechanical properties for a given
bone mass were attributable to substantial deﬁcits in tissue
material properties. We ﬁrst used beam theory to estimate the
tissuematerial properties from thebending tests (Table3). Results
indicated that diabetes but not obesity reduced the tissue
modulus by 16% (p< 0.05), the tissue yield strength by 28%
(p< 0.01), and the tissue ultimate strength by 12% (p< 0.05). To
complement these results, the contralateral ulnae from the lean
LSD rats and UCD-T2DM rats were loaded in uniaxial tension
(Table 3). Tensile measurements corroborated the diabetes-
induced reduction in tissue modulus and further revealed that
diabetes reduced the uniaxial tissue yield strain by 24%
(p< 0.005) and ultimate strain, or ductility, by 31% (p< 0.05).
To gain insight into the deﬁcits in tissue material properties
observed in UCD-T2DM rats, we used SAXS to measure the
speciﬁc strain in the collagen ﬁbrils associated with their
deformation during uniaxial tensile testing. Below 0.5% tissue
strain, there was no signiﬁcant difference between collagen ﬁbril
strain in the bones from diabetic rats and lean controls (Fig. 3A).
However, above 0.5% tissue strain, diabetes reduced ﬁbril strain
by nearly one-half. At the ultimate tissue strain, diabetes
reduced the ultimate ﬁbril strain by 40% (p< 0.05; Fig. 3B).
Diabetes increases AGE concentrations in bone
As expected from our previous study,(32) hyperglycemia
signiﬁcantly increased AGE levels (Fig. 3C). In the rats with
diabetes, AGE concentrations in the ulna mid-diaphyses were
27% higher compared with lean LSD control rats (0.37 0.013
versus 0.29 0.014 ng quinine ﬂuorescence/mg collagen;
p< 0.05). AGE levels in the ulnae from obese rats without
diabetes (0.33 0.013 ng quinine ﬂuorescence/mg collagen)
were not statistically different from lean controls (p¼ 0.30).
Relative contributions of tissue material properties
versus bone geometry and microarchitecture
The impairments in whole-bone stiffness and strength per unit
bone mass caused by diabetes were attributable to deﬁcits in
Table 3. Tissue Material Properties of Right and Left Ulnae Determined by Three-Point Bending and Uniaxial Tension (Mean  SE)
Lean (n¼ 6 rats) Obese (n¼ 6 rats) Diabetic (n¼ 6 rats) ANOVA p
Three-point bendinga
Tissue modulus (GPa) 18.3 0.7 18.5 0.6 15.4 0.8b,c 0.013
Yield stress (MPa) 251 2 245 14 182 11b,c 0.003
Ultimate stress (MPa) 280 5 276 7 246 9b,c 0.015
Uniaxial tension
Tissue modulus (GPa) 18.1 1.6 14.8 1.3 0.141
Yield stress (MPa) 79 10 72 10 0.631
Yield strain (%) 0.33 0.02 0.25 0.02b 0.018
Ultimate stress (MPa) 92 10 92 12 0.792
Ultimate strain (%) 1.30 0.05 0.89 0.04b 0.022
aTissue material properties from three-point bend tests were derived using beam theory equations; strain derivations are only valid in the pre-yield
region of the stress-strain curve, so yield and post-yield strains are not reported.
bp< 0.05 versus control by post hoc test.
cp< 0.05 versus obese by post hoc test.
Fig. 3. Collagen ﬁbril deformation during ulna tensile testing was measured by SAXS. Diabetes reduced ﬁbril strain, particularly at tissue strains above
0.5% (A) and culminating with a 40% reduction in ﬁbril ultimate strain (B). Reductions in ﬁbril strain coincided with a 27% increase in AGEs (C). Data are
mean SE for n¼ 4 to 5 rats/group. ap< 0.05 versus control.
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vertebral geometry and trabecular microarchitecture and to
deﬁcits in tissue material properties. To estimate their relative
contributions, we compared high-resolution ﬁnite element
models of the bones from UCD-T2DM rats with and without
specimen-speciﬁc material properties to models of the bones
from lean controls. For the vertebrae, including the diminished
material properties (specimen-speciﬁc tissue modulus and yield
strain) caused by diabetes signiﬁcantly reduced stiffness by 7%
(Fig. 4A, p< 0.01) and yield force by 17.4% (Fig. 4B, p< 0.0001),
whereas modeling only the deﬁcits in vertebral geometry and
trabecular microarchitecture signiﬁcantly reduced yield force by
18% (Fig. 4B, p< 0.05). For the ulnae, including the diminished
material properties caused by diabetes reduced rigidity by 4.7%
(Fig. 4C, p¼ 0.07) and yield moment by 19.9% (Fig. 4D, p< 0.01),
whereas the differences in ulnar geometry had a small,
nonsigniﬁcant effect on rigidity and yield moment.
Discussion
These results show that T2D signiﬁcantly reduces whole-bone
stiffness and strength for a given bone mass. This was
attributable to two factors. First, diabetes was associated with
deﬁcits in bone geometry and trabecular microarchitecture
(Table 2). For the vertebrae, this included thinner and more rod-
like trabeculae, which are more prone to bending deformations
that require only a small amount of tissue failure.(15) For the
ulnae, this included inefﬁcient distribution of bone mass;
diabetes led to a greater amount of bone matrix at the anterior
and posterior aspects of the diaphysis, which provides minimal
resistance to medial-lateral bending despite the increase in
overall bone mass. Second, the lower whole-bone stiffness and
strength for a given bone mass that associated with diabetes
was attributable to substantial deﬁcits in tissue material
properties (Table 3). Tissue ductility is conferred primarily by
collagen ﬁbril deformation. Our data show for the ﬁrst time that
T2D signiﬁcantly impairs collagen ﬁbril deformation, ie, that the
collagen in T2D-affected bone cannot carry as much strain, and
that these nanoscale changes in collagen behavior coincidewith
deﬁcits in the elastic, yield, and ultimate properties of the bone
tissue. Importantly, the net biomechanical effects of these
material property deﬁcits were substantial. Prescribing T2D-
speciﬁc tissue yield strains in high-resolution ﬁnite element
models reduced vertebral strength by 17.4%, a similar amount as
the structural deﬁcits (18%). For the ulnae, the effects of material
property deﬁcits on bone strength were 3.4-fold greater than
the structural deﬁcits (19.9% versus 5.8%). Taken together, these
ﬁndings provide new insight into the factors that increase bone
fragility for a given bone mass in T2D; not only does T2D
associate with alterations to bone geometry/microarchitecture
that make the structure less biomechanically efﬁcient, but T2D
also reduces tissue ductility by impairing collagen ﬁbril
deformation, and in doing so, reduces the maximum load
capacity of the bone.
A novel ﬁnding of this study is that diabetes signiﬁcantly
reduced collagen ﬁbril deformation. In healthy bone, collagen
ﬁbril deformation such as stretching and sliding is a primary
intrinsic toughening mechanism that confers ductility to the
tissue.(35,44,45) Fibril stretching is believed to predominate at
smaller applied strains, whereas ﬁbril sliding is thought to
predominate at larger applied strains and contribute to the
tissue’s ability to deform plastically.(44) Here, diabetes reduced
ﬁbril strain for a given tissue strain at larger applied strains
(>0.5%; Fig. 3A)—implying that the ﬁbrils have become stiffer
with diabetes—and there was a 40% reduction in ultimate ﬁbril
strain (Fig. 3B). Without this form of energy dissipation at the
mineralized ﬁbril scale, there is less resistance to microcrack
initiation and propagation, and there is degradation in the
ductility and intrinsic toughness of the bone.(44) Thus, we believe
that reduced collagen ﬁbril deformation due to impaired ﬁbril
sliding explains why the bones from diabetic rats exhibited a
24% lower tissue yield strain and 31% lower tissue ductility
compared to the bones from lean controls. These deﬁcits in
collagen behavior and tissue ductility with diabetes reduce the
load capacity of the bone, and they coincided with 27% higher
concentrations of non-enzymatic cross-links (AGEs). Results from
previous studies indicate that AGE accumulation with aging
reduces collagen ﬁbril deformation(44) and that diabetes
accelerates AGE accumulation.(10) Our current results extend
those prior ﬁndings by showing that increased AGE accumula-
tion with diabetes associates with reduced collagen deforma-
tion, and that the corresponding reduction in tissue yield strain
accounts for a large proportion of the overall loss in whole-bone
strength.
Our results showed that T2D associates withweaker ulnae and
vertebrae than would be predicted based on bone mass alone.
Fig. 4. High-resolution ﬁnite element analysis of the vertebrae (A, B) and
ulnae (C, D) was used to estimate the relative roles of diabetes-induced
deﬁcits in bone geometry and architecture versus material properties.
Vertebral behavior was evaluated in compression; ulnar mid-shaft
behavior was evaluated in three-point bending. For the elastic
biomechanical properties (A, C), models of the bones from lean control
rats and those with diabetes were assigned either the average tissue
modulus of the bones in the control group or the specimen-speciﬁc
tissue modulus derived from the mCT-based measurements of tissue
mineral density. For the biomechanical properties at yield (B, D), models
of the bones were assigned either the average tissuemodulus and tissue
yield strain of the bones in the control group or the specimen-speciﬁc
tissue modulus and yield strain measured from the SAXS experiments.
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Fracture risk assessment is based on areal BMD by DXA—a
measure of bone quantity that is highly correlated with DXA-
derived bonemass.(8) Yet, adults with T2D have a higher fracture
risk than would be predicted based on their bone quantity.(7)
Here, weaker bone strength for a given bone mass in diabetes
was attributable to deﬁcits in tissue material properties and
bone structure. Although requiring conﬁrmation in humans, our
ﬁndings suggest that knowledge about both tissue material
properties and bone structure may improve fracture risk
assessment in T2D. Clinical methodologies for measuring
material properties and bone structure in patients with T2D
using reference point indentation(14) and high-resolution
peripheral quantitative computed tomography(25,26) are prom-
ising, but these methodologies are not widespread and
prospective studies are needed. Related, our ﬁndings also
suggest that antifracture treatments may need to improve both
tissue material properties and structure to fully restore bone
strength in a diabetic milieu. Little is known about the effects of
antifracture treatment in subjects with T2D.(46) The effects of
glycemic control on AGEs in bone are also unclear; reducing any
excessive intake of dietary AGEs may be important too.(47)
Another notable ﬁnding is that insulin resistance and
hyperglycemia had distinct effects on bone structure and
material properties. Both obese insulin-resistant OSD rats and
UCD-T2DM rats with hyperglycemia had lower whole-bone
biomechanical properties per unit bonemass; however, only the
rats with hyperglycemia had signiﬁcant impairments in tissue
material properties. Although OSD rats had 2.5% lower vertebral
TMD and 3.1% lower ulnar TMD, assigning specimen-speciﬁc
tissuematerial properties based on TMD in high-resolution ﬁnite
element models of the OSD rats’ bones reduced vertebral
stiffness and ulna rigidity by just 2.8% and 2.2%, respectively
(data not shown). In combination with the similar tissuematerial
properties derived from the bending tests of OSD and LSD ulnae,
these ﬁndings suggest that the lower whole-bone biomechani-
cal properties per unit bone mass in the obese, normoglycemic
rats is attributable mainly to structural deﬁciencies. For the
vertebra, we believe this is mainly arises due to the lower
percentage of cortical bone, which has a greater load-bearing
role.(39) For the ulna, we believe this mainly reﬂects the
inefﬁcient distribution of bone mass. Moreover, bone mass
was signiﬁcantly higher at both sites. This is consistent with
evidence from human studies that report more trabecular and
cortical bone at the distal radius and tibia in obese individu-
als(48,49); however, additional research is needed to clarify
whether differences in the distribution of bonemass explain the
association between obesity and higher fracture risk for a given
bone quantity.(50)
This study had several limitations. Most important, we did not
study animals with an advanced duration and severity of
diabetes, which may limit the generality of the conclusions.
However, because reductions in collagen deformation coincided
with AGE accumulation, and because AGEs increase with
diabetes duration and severity,(12,22) bone biomechanical
behavior would both be expected to progressively worsen
with a longer duration of diabetes and greater degree of
hyperglycemia. This is consistent with ﬁndings in bones from
Zucker Diabetic Sprague Dawley (ZDSD) rats, where AGEs and
biomechanical impairments increased with disease duration.(12)
A second limitation is that we used a nondiabetic control rat that
is not a littermate or the same strain. Thus, we did not account
for any potential strain-related differences that might have
contributed to the observed bone phenotype. However, we
believe the bonephenotype in theUCD-T2DM ratsmainly reﬂects
the effects of diabetes, and future studies are needed to evaluate
the impact of any strain-related differences. It is alsoworth noting
that we focused on the ulna because its length-to-width ratio
makes it suitable for estimating tissue material properties from
beam theory equations. Although the ulna is not a primary
fracture site in humans, our results from the ulnar mid-diaphysis
should be representative of long-bone behavior in general. A
technical limitation is that the assumed constitutive model used
in the nonlinear ﬁnite element analyses incorporated only the
elastic and yield behavior of the bone tissue, and thus our
simulations did not include post-yield behavior or fracture. Since
individual trabeculae rarely fracture before the yield point of the
structure,(51,52) we expect that our ﬁnite element-derived
conclusions about whole-bone biomechanical properties at yield
are valid despite this limitation. Finally, our simulations assumed
that diabetes had similar effects on the material properties of
cortical and trabecular bone, and this remains to be conﬁrmed.
Results from a glycation study indicate that trabecular bone may
accumulatemoreAGEs thancortical bone,(53)which suggests that
the estimated contribution ofmaterial property deﬁcits towhole-
vertebral behavior is conservative.
In summary, these ﬁndings showed that in addition to causing
alterations to the bone structure that make it less biomechani-
cally efﬁcient for a given bone mass, T2D reduces tissue ductility
by impairing collagen ﬁbril deformation, and in doing so,
reduces themaximum load capacity of the bone. The diminished
tissue material properties were speciﬁc to the rats with
hyperglycemia and coincided with high concentrations of
AGEs. Taken together, these results provide mechanistic insight
into the structural and material contributors to diabetic bone
fragility, and suggest that both bone structure and material
properties may be important targets to more accurately assess
fracture risk in T2D and to develop treatment strategies.
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